A study to evaluate Anti-JCV antibody serostatus in multiple sclerosis patients with long-term use of Natalizumab
Latest Information Update: 21 Nov 2016
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 21 Nov 2016 New trial record